6alpha-羟基睾酮结构式
|
常用名 | 6alpha-羟基睾酮 | 英文名 | (6S,8R,9S,10R,13S,14S,17S)-6,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
---|---|---|---|---|
CAS号 | 2944-87-8 | 分子量 | 304.42400 | |
密度 | 1.19g/cm3 | 沸点 | 479.8ºC at 760 mmHg | |
分子式 | C19H28O3 | 熔点 | N/A | |
MSDS | 中文版 美版 | 闪点 | 258.1ºC | |
符号 |
GHS07, GHS08 |
信号词 | Warning |
中文名 | 6alpha-羟基睾酮 |
---|---|
英文名 | (6S,8R,9S,10R,13S,14S,17S)-6,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
英文别名 | 更多 |
密度 | 1.19g/cm3 |
---|---|
沸点 | 479.8ºC at 760 mmHg |
分子式 | C19H28O3 |
分子量 | 304.42400 |
闪点 | 258.1ºC |
精确质量 | 304.20400 |
PSA | 57.53000 |
LogP | 2.85000 |
蒸汽压 | 3.19E-11mmHg at 25°C |
折射率 | 1.578 |
分子结构 | 1、 摩尔折射率:84.62 2、 摩尔体积(cm3/mol):254.9 3、 等张比容(90.2K):678.6 4、 表面张力(dyne/cm):50.1 5、 极化率(10-24cm3):33.54 |
计算化学 | 1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:2 3.氢键受体数量:3 4.可旋转化学键数量:0 5.互变异构体数量:2 6.拓扑分子极性表面积57.5 7.重原子数量:22 8.表面电荷:0 9.复杂度:539 10.同位素原子数量:0 11.确定原子立构中心数量:7 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
符号 |
GHS07, GHS08 |
---|---|
信号词 | Warning |
危害声明 | H302-H312-H332-H351-H361 |
警示性声明 | P280 |
个人防护装备 | Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
危害码 (欧洲) | Xn: Harmful; |
风险声明 (欧洲) | R20/21/22;R40;R63 |
安全声明 (欧洲) | S22-S36 |
危险品运输编码 | NONH for all modes of transport |
~% 6alpha-羟基睾酮 2944-87-8
详细
|
文献:Steroids, , vol. 70, # 4 p. 327 - 333 |
6alpha-羟基睾酮上游产品 1 | |
---|---|
6alpha-羟基睾酮下游产品 0 |
Testosterone-metabolizing capacity and characteristics of adrenal microsomes in human fetus in vitro.
J. Pediatr. Endocrinol. Metab. 23(1-2) , 143-52, (2010) We describe the metabolite spectrum of testosterone (T) in human fetal adrenal in vitro, and verify possible roles of CYP3A and 2C isoforms of human fetal adrenal in T metabolism which respond to T me... |
|
The hepatic and intestinal metabolic activities of P450 in rats with surgery- and drug-induced renal dysfunction.
Pharm. Res. 20(10) , 1591-4, (2003) The hepatic and intestinal metabolic activities of P450 were evaluated in rats with surgery- and drug-induced renal dysfunction.Renal failure was induced by five-sixths nephrectomy (NR), bilateral ure... |
|
The use of heat treatment to eliminate drug interactions due to grapefruit juice.
Biol. Pharm. Bull. 29(11) , 2274-8, (2006) Grapefruit juice (GJ) contains components that may increase the bioavailability of drugs; however, approaches to the removal of these components have been little investigated. It is known that furanoc... |
6alpha-Hydroxytestosterone |
6-hydroxytestosterone |
4-androstene-6alpha,17beta-diol-3-one |
Androst-4-ene-6|A,17|A-diol-3-one |
4-Androstene-6|A,17|A-diol-3-one |
6|A-Hydroxytestosterone |